Stay updated on Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page.

Latest updates to the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer indicates an updated ClinicalTrials.gov software/site revision number, moving from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck and Small cell lung carcinoma to the list of conditions. Added Genetic and Rare Diseases Information Center as a related resources reference.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Naples, Italy (80131) as a study site and updated the city name from Napoli to Naples.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page shows a minor site version update with Revision: v3.4.2 added and Revision: v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page.